BIOMAT Database Logo BIOMAT Database Logo

Re: Circulating prostate specific antigen-positive cells correlate with metastatic prostate cancer. 1993

R J Ablin

UI MeSH Term Description Entries
D008297 Male Males
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017430 Prostate-Specific Antigen A glycoprotein that is a kallikrein-like serine proteinase and an esterase, produced by epithelial cells of both normal and malignant prostate tissue. It is an important marker for the diagnosis of prostate cancer. Kallikrein hK3,gamma-Seminoprotein,hK3 Kallikrein,Prostate Specific Antigen,Semenogelase,Seminin,Kallikrein, hK3,gamma Seminoprotein

Related Publications

R J Ablin
Circulating prostate specific antigen-positive cells correlate with metastatic prostate cancer.
April 1992, British journal of urology,
R J Ablin
Detection of prostate-specific antigen- or prostate-specific membrane antigen-positive circulating cells in prostatic cancer patients: clinical implications.
October 1999, European urology,
R J Ablin
Changes in circulating carcinoma cells in patients with metastatic prostate cancer correlate with disease status.
September 2001, Urology,
R J Ablin
Detection of circulating prostate-specific antigen-secreting cells in prostate cancer patients.
August 2005, Clinical chemistry,
R J Ablin
Metastatic prostate cancer with a normal prostate-specific antigen level.
October 2005, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico,
R J Ablin
Circulating prostate-specific antigen/CD14-double-positive cells: a biomarker indicating low risk for hematogeneous metastasis of prostate cancer.
January 1997, Journal of the National Cancer Institute,
R J Ablin
Comparison of circulating MicroRNA 141 to circulating tumor cells, lactate dehydrogenase, and prostate-specific antigen for determining treatment response in patients with metastatic prostate cancer.
September 2011, Clinical genitourinary cancer,
R J Ablin
Prostate specific antigen expression does not necessarily correlate with prostate cancer cell growth.
July 2006, The Journal of urology,
R J Ablin
Metastatic prostate cancer with normal level of serum prostate-specific antigen.
January 2003, International urology and nephrology,
R J Ablin
Metastatic prostate cancer to lung with normal prostate specific antigen levels.
February 2004, Hospital medicine (London, England : 1998),
Copied contents to your clipboard!